Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma

Abstract Immune checkpoint inhibitor (ICI) treatments produce clinical benefit in many patients. However, better pretreatment predictive biomarkers for ICI are still needed to help match individual patients to the treatment most likely to be of benefit. Existing gene expression profiling (GEP)-based...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuanliang Cui, Canqiang Xu, Wenxian Yang, Zhihong Chi, Xinan Sheng, Lu Si, Yihong Xie, Jinyu Yu, Shun Wang, Rongshan Yu, Jun Guo, Yan Kong
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Online Access:https://doaj.org/article/e97b11a5b0b44e6cb64f859733a26b77
Tags: Add Tag
No Tags, Be the first to tag this record!